March 11, 2020
George Farmer told investors that BMO Capital Markets is lowering its price target for BridgeBio Pharma to US$46, down from...
January 30, 2020
Alexion Pharmaceuticals announced its financial results for the fourth quarter and its full fiscal 2019 year.
March 26, 2019
A report by Cortellis says that seven drugs entering the market in 2019 are projected to reach blockbuster status by...
September 24, 2018
Alexion Pharmaceuticals (NASDAQ:ALXN) today announced positive topline results from the Phase 3 PREVENT study of Soliris (eculizumab) in patients with anti-aquaporin-4 (AQP4)...
June 28, 2018
Alexion Pharmaceuticals (NASDAQ:ALXN) announced the submission of a Marketing Authorization Application to the European Medicines Agency (EMA) for ALXN1210, the...
February 26, 2018
Investors and analysts are focusing on KemPharm and Achillion after both companies received recent positive regulatory news.
April 25, 2017
biOasis Technologies announced the appointment of Dr. Mark Day as president and CEO of the company.